(NYSE: TMO) Thermo Fisher Scientific's forecast annual revenue growth rate of 4.68% is not forecast to beat the US Diagnostics & Research industry's average forecast revenue growth rate of 5.29%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.7%.
Thermo Fisher Scientific's revenue in 2025 is $42,879,000,000.On average, 8 Wall Street analysts forecast TMO's revenue for 2025 to be $16,554,893,322,848, with the lowest TMO revenue forecast at $16,518,085,081,103, and the highest TMO revenue forecast at $16,635,709,081,472. On average, 8 Wall Street analysts forecast TMO's revenue for 2026 to be $17,628,259,861,121, with the lowest TMO revenue forecast at $17,431,730,175,492, and the highest TMO revenue forecast at $17,825,760,617,032.
In 2027, TMO is forecast to generate $19,081,740,430,452 in revenue, with the lowest revenue forecast at $18,975,439,924,461 and the highest revenue forecast at $19,223,913,193,195.